Quick Answer
Skye Bioscience, Inc. reported Net Income of -$55.92 million for fiscal year 2025.
Skye Bioscience, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$55.92M | -110.5% |
| 2024 | -$26.57M | +29.4% |
| 2023 | -$37.64M | -93.2% |
| 2022 | -$19.48M | -128.6% |
| 2021 | -$8.52M | -29.9% |
| 2020 | -$6.56M | -723.7% |
| 2019 | $1.05M | +105.5% |
| 2018 | -$19.19M | -520.3% |
| 2017 | -$3.09M | +2.6% |
| 2016 | -$3.18M | +34.4% |
| 2015 | -$4.84M | -77.1% |
| 2014 | -$2.73M | -2170.8% |
| 2013 | -$120.4K | -3083.6% |
| 2013 | -$3.8K | -183.9% |
| 2012 | $4.5K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.75M | -227.2% | +27.6% |
| June 30, 2025 | -$17.62M | -123.0% | -58.7% |
| March 31, 2025 | -$11.10M | -121.2% | -184.8% |
| September 30, 2024 | -$3.90M | +84.4% | +50.7% |
| June 30, 2024 | -$7.90M | -154.0% | -57.4% |
| March 31, 2024 | -$5.02M | +2.9% | +79.9% |
| September 30, 2023 | -$24.95M | -697.7% | -701.7% |
| June 30, 2023 | -$3.11M | +9.0% | +39.8% |
- Skye Bioscience, Inc. showed a decrease of -110.5% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Skye Bioscience, Inc.’s net income has declined by 1240393.1% (from $4.5 thousand to -$55.92 million).
- The most recent figure is from Skye Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: